Alexa S. Beiser, PhD

Professor, Boston University School of Public Health

Biography

Alexa Beiser has been on the faculty at Boston University School of Public Health since 1985, engaged in teaching and collaborative public health research; she co-developed the doctoral program in biostatistics; co-directed the biostatistics program from 2000-2004, and served as Associate Chair for Education from 2015-2018. She formerly taught and coordinated the sections of Introduction to Statistical Computing. For more than twenty-five years, Dr. Beiser has served as the lead biostatistician for the Framingham Heart Study (FHS) neurology group, examining risk factors and prevalence and incidence of clinical and sub-clinical neurological outcomes including MRI and PET measures of brain structure, cognitive performance, dementia, Alzheimer’s disease, stroke, Parkinson’s disease, and epilepsy. Dr. Beiser currently leads the FHS neurology group data management team, responsible for surveillance and tracking of incident dementia, for supervision of recruitment of participants for various grant-funded studies, and for management of data collected at FHS as well as those measured or processed at other institutions (e.g., brain MRI or PET scans); and the FHS neurology group biostatistics team of six biostatisticians. Decades of examining risk factors for neurological diseases has naturally led to studying factors associated with accelerated brain aging. Dr. Beiser has coauthored FHS publications relating risk factors including midlife vascular factors, plasma homocysteine, plasma leptin levels, cardiac index, red blood cell omega-3 fatty acids, metabolic dysregulation, visceral fat, air pollution; serum brain-derived neurotrophic factor; and insulin-like growth factor 1, to measures of brain aging. Dr. Beiser also has made use of the richness of the multigenerational Framingham data to relate documented parental dementia and stroke to offspring stroke, cognitive performance, and MRI measures of brain structure. In investigations of clinical neurological endpoints, she has applied competing risk analyses and has also been able to investigate temporal trends in prevalent and incident neurological disease due to the availability of event surveillance over many decades. In all these studies, Dr. Beiser plays a key role in project conceptualization, is responsible for supervision of statistical data management, analysis, and interpretation of results, and contributes to manuscript preparation and critical review.

Publications

  • Published 10/7/2026

    Lioutas VA, Aparicio HJ, Romero JR, Himali D, Ghosh S, Ramachandran V, Beiser A, Seshadri S, Himali J. Transient Ischemic Attack as a Marker of Coronary Heart Disease: A Population-Based Study. Neuroepidemiology. 2026 Oct 07; 1. PMID: 42842534.

    Read at: PubMed

  • Published 9/24/2026

    Cooper LL, Banerjee A, Beiser AS, Charisis S, Hamel-Sellman DJ, Korzinski TJ, Benjamin EJ, Hamburg NM, Vasan RS, Seshadri S, Mitchell GF. Associations of Brain Structure and Neuropsychological Function With Artificial Intelligence Estimates of Biological Vascular Age. Arterioscler Thromb Vasc Biol. 2026 Nov; 46(11):e325247. PMID: 42779540.

    Read at: PubMed

  • Published 9/7/2026

    Manchanda R, Pinheiro A, Aparicio HJ, Lioutas VA, Beiser AS, Sisto J, Ekenze O, Benjamin EJ, DeCarli C, Seshadri S, Romero JR. Cerebral Small Vessel Disease and Risk of Cardiovascular Events and All-Cause Mortality: The Framingham Heart Study. medRxiv. 2026 Sep 07. PMID: 42818802.

    Read at: PubMed

  • Published 8/30/2026

    Mulligan MD, Wang R, Yang Q, Beiser AS, Maillard P, Satizabal C, Ghosh S, Tanner J, Johnson KA, DeCarli C, Tracy RP, Levy D, Benjamin EJ, El Fakhri G, Vasan RS, Seshadri S, McGrath ER. Mid-life candidate vascular plasma biomarkers are associated with MRI markers of vascular brain injury and amyloid- and tau-PET in cognitively healthy adults. J Alzheimers Dis. 2026 Oct; 113(4):1674-1699. PMID: 42669799.

    Read at: PubMed

  • Published 8/19/2026

    Yiannakou I, Jacques PF, Long MT, Beiser A, Pickering RT, Moore LL. Development and validation of a modified Dietary Approaches to Stop Hypertension (mDASH) index in the community-based Framingham Heart Study Second Generation cohort. Clin Nutr. 2026 Nov; 66:106766. PMID: 42753339.

    Read at: PubMed

Other Positions

  • Professor, Neurology
    Boston University Chobanian & Avedisian School of Medicine
  • Investigator
    Framingham Heart Study

Education

  • Boston University, PhD
  • University of California, San Diego, MA
  • University of California, Santa Cruz, BA